- Podrobná studie automatické desambiguace sloves v češtině +42006 | Matematicko-fyzikální fakulta
- Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology2015 | 1. lékařská fakulta
- The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy2019 | 1. lékařská fakulta
- Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS2024 | 2. lékařská fakulta
- Hepatoprotective properties of extensively studied medicinal plant active constituents: Possible common mechanisms2015 | 1. lékařská fakulta
- Dlouhodobá léčba fingolimodem u roztroušené sklerózy - výsledky 4,5leté extenze studie TRANSFORMS2016 | Publikace bez příslušnosti k fakultě
- Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension2024 | Publikace bez příslušnosti k fakultě
- Studie OLE - Open Lable Extension fáze studie Clarinet s lanreotidem Autogel 120 mg u metastatických enteropankreatických neuroendokrinních nádorů2016 | 1. lékařská fakulta
- Dlouhodobé výsledky terapie infliximabem u pacientů s ulcerózní kolitidou. Pokračování studií ACT-1 a ACT-22012 | 1. lékařská fakulta
- Studie HYVET-extenze: prospěch léčby vysokého krevního tlaku u velmi starých pacientů s hypertenzí2014 | 1. lékařská fakulta
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)2015 | 1. lékařská fakulta
- Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies2022 | 1. lékařská fakulta
- Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study2016 | 1. lékařská fakulta
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study2019 | 1. lékařská fakulta
- Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration : a randomised, double-blind, controlled trial and an open-label extension study2019 | 1. lékařská fakulta
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study2016 | 1. lékařská fakulta
- Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study2021 | 1. lékařská fakulta
- Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study2020 | 1. lékařská fakulta
- Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study2019 | 1. lékařská fakulta
- Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)2014 | 2. lékařská fakulta
- Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study2020 | 1. lékařská fakulta
- Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosisPublikace bez příslušnosti k fakultě
- Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study2017 | 1. lékařská fakulta
- Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study2020 | Publikace bez příslušnosti k fakultě
- Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months2022 | 1. lékařská fakulta
- Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study2022 | 1. lékařská fakulta